The future of CMC for novel therapies

Elena Meurer | Principal Consultant and CMC at BioPharma Excellence

Novel and advanced therapies have come on in leaps and bounds over the past decade. Some cell and gene therapies have already reached the approvals stage, while others have now entered the later development stages

Start a conversation today